4,945
Confirmed Cases
DRC INSP/government data, reported Aug 17 (data thru Aug 16) · 6 provinces
2,325
Confirmed Deaths
CFR ~47.0% · 1,040 recoveries · now deadliest outbreak in DRC's history
~10%
Expected contacts listed
82.6% follow-up on those listed · Kaseya, Aug 13: tracing "has become useless"
97d
Outbreak duration
PHEIC: Day 95 · 2nd IHR Emergency Committee met Aug 18, outcome pending · Israel's 3rd suspected case: negative
Critical Context
Five Factors That Separate This From Prior Outbreaks
New (Aug 19) — Second IHR Emergency Committee meets in Geneva; Israel's third suspected case resolved negative: The second meeting of the IHR Emergency Committee on this outbreak was held August 18 in Geneva, chaired by Prof. Lucille Blumberg, with representatives of DRC, Uganda and France attending. In his published opening remarks, WHO Director-General Tedros Adhanom Ghebreyesus told the Committee the outbreak has infected "almost 5000" people and killed "more than 2,300" across six provinces and 55 health zones — consistent with, not additive to, the existing 4,945/2,325 figure reported Aug 17 — and said bluntly: "We must be frank: the epidemic is far from being under control... It had a big head start, and we are still playing catch-up." He confirmed Uganda has stopped transmission following its initial spillover, that a traveller carried the virus to France last month with no secondary transmission detected, that the WHO-sponsored PARTNERS treatment trial has now enrolled 100 patients, and that two Bundibugyo-specific vaccines have entered human trials for the first time, with a third showing cross-protection in animal studies and advancing toward a Phase 3 trial. No formal Committee statement or outcome on PHEIC status has been published as of this update — the emergency remains in effect unchanged pending that statement. Separately, Israel's third suspected case (Soroka Medical Center, reported Aug 11) has been resolved: the patient tested negative for Ebola. All three Israeli suspected cases during this outbreak have now tested negative, and Israel still has no confirmed case. (WHO Director-General's opening remarks, Aug 18; Israeli press reporting)
Superseded (Aug 18) — Outbreak becomes the deadliest Ebola epidemic in DRC's history: WHO said Monday, August 17, that the death toll — now 2,325 — has surpassed the 2,299 deaths recorded in the DRC's 2018–2020 North Kivu epidemic, making this the deadliest Ebola outbreak the country has ever faced. DRC's National Public Health Institute (INSP) puts the latest count at 4,945 confirmed cases and 2,325 deaths — a CFR of roughly 47.0% (cited elsewhere as "~46%") — with 1,040 recoveries and 730 patients hospitalized in isolation, as of data through August 16, reported Sunday, August 17. That's up from the 4,727/2,214 figure used in yesterday's update (+218 cases, +111 deaths over two days), including +101 cases and +53 deaths in the most recent single 24-hour period — new cases from Ituri (89), North Kivu (8), Haut-Uele (3) and Tshopo (1). Deaths are being recorded at a rate of roughly one every 28 minutes over the past week, per WHO. WHO Director-General Tedros Adhanom Ghebreyesus warned that at its current pace the outbreak is "almost certain" to eventually eclipse the 2014–2016 West Africa epidemic (28,616 cases / 11,310 deaths) too, unless testing, contact tracing and isolation are drastically scaled up — this brief notes the outbreak remains the second-largest Ebola outbreak by case count and is still far short of West Africa's death toll, so "deadliest in DRC's history" and "largest/deadliest ever recorded" remain two distinct claims, and only the first is true today. The IHR Emergency Committee is scheduled to reconvene today, August 18, to reassess PHEIC status; no outcome has been reported as of this update. No new provinces, no confirmed South Sudan cases, no new American or international cases, no confirmed Kinshasa transmission, Israel's third suspected case still unresolved in available reporting, and Uganda's outbreak remains closed (declared over Jul 28). (UN News, CGTN, Al Jazeera, Techtimes, Irish Times, Bloomberg — citing WHO and DRC government data, Aug 17)
Superseded (Aug 17) — Case count rises to 4,727 / 2,214; more than 63% of deaths now occurring in communities, not treatment centres: The DRC health authorities' latest report, released Friday and reported by CGTN/Xinhua on August 16, puts the outbreak at 4,727 confirmed cases and 2,214 deaths — a CFR of 46.8%, with 976 recoveries — up from 4,665/2,184 in yesterday's update (+62 cases, +30 deaths). Affected health zones rise to 55 (from 54) across the same six provinces, with Ituri still the epicenter and Buta (Bas-Uele) the newest affected zone. The most operationally significant disclosure: Africa CDC Director-General Dr. Jean Kaseya said more than 63% of Ebola deaths are now occurring in communities rather than in treatment centres or hospitals. That figure both explains and compounds the tracing failure already documented in this brief — a death outside the health system leaves responders with no record of who the patient contacted before or after death, and makes safe and dignified burial substantially harder. The same report puts contact follow-up at 82.6% of registered contacts (up marginally from the 82.4% in AFRO Sitrep 13), with Africa CDC again stressing that the proportion of registered contacts being followed does not itself reflect tracing effectiveness when most contacts are never identified in the first place — consistent with the ~10%-of-expected-contacts-listed figure. WHO's Tedros said on August 12 that many new cases continue to be detected among people not on existing contact lists, indicating transmission chains that have yet to be identified. No PHEIC status change; the IHR Emergency Committee reconvenes tomorrow (Aug 18). No new provinces, no confirmed South Sudan cases, no new American or international cases, no confirmed Kinshasa transmission, Israel's third suspected case still unresolved in available reporting, and Uganda's outbreak remains closed (declared over Jul 28). (CGTN/Xinhua citing DRC health authorities and Africa CDC — Aug 16)
New (Aug 17) — Africa CDC to retrospectively reconstruct the outbreak's undocumented February–May period: Africa CDC is pushing a village-based response that would, alongside forward surveillance, attempt to reconstruct the epidemic's pre-declaration phase. Communities will be asked to identify people who died or fell ill with Ebola-like symptoms between January and May 2026; where laboratory confirmation is no longer possible, community recall could still let authorities estimate how much transmission occurred before the outbreak was formally detected on May 15. Kaseya was blunt about the gap: "We have no clue about what happened from February to May," adding that figures collected since the declaration should not necessarily be regarded as a complete picture of the epidemic. Dr. Chikwe Ihekweazu, executive director of the WHO Health Emergencies Programme, said investigations so far suggest the virus may have been circulating two to three months before formal detection, though the exact start of transmission remains under investigation. This corroborates WHO AFRO Regional Director Dr. Mohamed Janabi's August 10 statement that genomic sequencing points to a February 2026 start in Mongbwalu, with early cases misattributed to malaria and typhoid. Analytical note: if the reconstruction confirms a February start, current case counts represent a floor rather than a full accounting, and growth-rate comparisons against the 2014–2016 West Africa epidemic — measured from declaration date — would understate this outbreak's true velocity. (CGTN/Xinhua citing Africa CDC and WHO — Aug 16)
Superseded (Aug 16) — Case count rises to 4,665 / 2,184; DRC requests 100,000 Ervebo doses for expanded emergency vaccine use: DRC public health authorities, via an Africa CDC online briefing reported by CGTN/Xinhua on August 15, put the outbreak at 4,665 confirmed cases and 2,184 deaths — a CFR of 46.8%, with 965 recoveries and 634 patients hospitalized in isolation — up from the 4,566/2,128 figure used in yesterday's update. The health zone of Buta (Bas-Uele) has been added to DRC's own list of affected areas, bringing the total to 54 health zones across six provinces. The most significant development: Africa CDC Director-General Dr. Jean Kaseya announced DRC has requested 100,000 doses of the licensed ERVEBO vaccine from the International Coordinating Group (ICG) for expanded emergency use — a step beyond the Phase 3 ring trial reported Aug 7 — to vaccinate frontline responders, high-risk contacts, healthcare workers, burial teams, and religious/village leaders in high-transmission areas, while generating scientific evidence on cross-protection against Bundibugyo virus. Kaseya: "The current emergency risks becoming the deadliest the country has faced, and we cannot allow that trajectory to continue." The expanded-use decision was among measures agreed at last week's Kinshasa crisis meeting between President Tshisekedi, Kaseya, and WHO's Tedros. No PHEIC status change; the IHR Emergency Committee reconvenes in 2 days (Aug 18). Israel's third suspected case (Soroka Medical Center) remains unresolved in available reporting. No confirmed South Sudan cases (DRC cases remain ~35km from the border). No new American/international cases, no confirmed Kinshasa transmission, and Uganda's outbreak remains closed (declared over Jul 28). (CGTN/Xinhua, Africa CDC briefing — Aug 15)
Superseded (Aug 15) — Case count refined to 4,566 / 2,128; Kaseya warns outbreak could run "more than a year" and become the largest in the world: DRC government data reported by Al Jazeera/AP on August 14 (figures thru August 11) puts the outbreak at 4,566 confirmed cases and 2,128 deaths — a CFR of 46.6% — essentially confirming the "4,500+/2,100+" AP estimate used in yesterday's update. Speaking on the Bas-Uele expansion, Africa CDC Director-General Dr. Jean Kaseya delivered his starkest warning yet: "If we do not stop this outbreak, it will last more than a year and will be the largest in the world." That echoes WHO Director-General Tedros's August 12 assessment that the epidemic is on track to surpass the 2014–2016 West Africa outbreak. Separately, WHO's regional situation report (AFRO Weekly External Sitrep 13, data as of Aug 9) puts contact follow-up at 82.4% of already-listed contacts across Ituri, North Kivu, South Kivu, Haut-Uele and Tshopo — a different pipeline stage than Africa CDC's Aug 13 figure that only ~10% of expected contacts have been listed in the first place; the two figures are not in conflict, but together they show a tracing system that is both under-registering contacts and, for the minority it does register, following most of them. Local reporting (Radar Africa, Aug 14) also clarifies that Bas-Uele has not yet been formally added to WHO's official list of affected provinces, since authorities have not yet confirmed local (secondary) transmission there — contact tracing on the index case's known contacts is ongoing. No PHEIC status change; the IHR Emergency Committee reconvenes in 3 days (Aug 18). No new American or international cases, no confirmed Kinshasa transmission, and Uganda's outbreak remains closed (declared over Jul 28). (Al Jazeera/AP, PBS/Reuters, WHO AFRO, Radar Africa — Aug 14)
New (Aug 14) — Outbreak reaches a sixth province; Africa CDC says contact tracing "has become useless": Africa CDC Director-General Dr. Jean Kaseya confirmed the outbreak has spread to a sixth of DRC's 26 provinces after a motorcycle-taxi driver died in Buta, capital of the previously unaffected Bas-Uele province, having traveled there from Isiro in Haut-Uele. Congo's National Institute for Biomedical Research (INRB) director Jean-Jacques Muyembe said the man's colleagues tried to forcibly take his body before police intervened — raising concern that more people were exposed. AP now puts the outbreak at more than 4,500 confirmed cases and over 2,100 deaths on the latest government figures, a toll reached almost three times faster than the 2014–2016 West Africa epidemic. Kaseya delivered the response's bluntest assessment yet: "the concept of contact tracing in DRC has become useless." WHO's Regional Director for Africa, Dr. Mohamed Janabi, added: "We are chasing the virus; the virus is ahead of us." Separately, health workers at the Nizi Treatment Center in Ituri — one of the most-affected facilities — struck Aug 13 over three months of unpaid wages, forcing its temporary closure; Kaseya called on the DRC government to release outstanding salaries, saying funds are available. Aid group Mercy Corps separately warned that cases have been reported along a travel route roughly 35km from DRC's border with South Sudan, citing concern over the outbreak's "widening footprint" — no cases have been confirmed in South Sudan. (AP via KSAT/Washington Times, Aug 13)
New (Aug 14) — Nature Medicine study: outbreak began with a new, independent animal-to-human spillover, not a re-emergence: A genomic study published this week in Nature Medicine, analyzing samples from 22 patients in DRC and Uganda, found the outbreak strain is genetically distinct from the Bundibugyo viruses behind the 2007 and 2012 outbreaks — indicating a new zoonotic spillover event from an as-yet-unidentified animal reservoir, rather than continued circulation or re-emergence of a previously known human-outbreak lineage. The study links the Uganda outbreak to the same spillover. Infectious-disease physician Dr. Krutika Kuppalli cautioned this does not mean a new form of Ebola has emerged or that transmission dynamics have changed — "after that initial spillover, the outbreak has been driven predominantly by human-to-human transmission." Separately, WHO's Dr. Abdirahman Mahamud said the agency's moderate projection has the outbreak peaking within six months, with a more severe scenario running 9–12 months, and confirmed two Bundibugyo-specific vaccine candidates have now entered human testing for the first time, alongside the Oxford Phase 1 trial already underway. (Nature Medicine via Al Jazeera explainer, Aug 13)
New (Aug 13) — Tedros: outbreak now on track to become the largest Ebola epidemic ever recorded; case count rises past 4,500 / 2,060 deaths: WHO Director-General Dr. Tedros Adhanom Ghebreyesus told a Geneva press conference on August 12 that the epidemic is "already the second-biggest Ebola epidemic on record, and it's moving faster than any previous Ebola outbreak. At its current pace, it's on track to eclipse the West African Ebola outbreak of 2014-2016" — which killed 11,310 people across Guinea, Liberia and Sierra Leone. As of Monday, August 10, WHO figures cited by Tedros put the outbreak at more than 4,500 confirmed cases and more than 2,060 deaths, running ahead of the Aug 11 DRC government count (4,381/2,011) used in yesterday's update. Separately, WHO's Dr. Vasee Moorthy said the agency is finalizing a Phase 3 vaccine-trial protocol for submission to DRC regulatory and ethics authorities: known contacts of cases would be individually randomized — not assigned by ring-vaccination as in the 2016 Guinea "Ebola Ça Suffit" trial that proved Ervebo's ~84% efficacy against Ebola Zaire — to receive Ervebo or placebo, with Bundibugyo-specific candidates (Oxford, Moderna's mRNA candidate, IAVI) potentially added once September Phase 1 data are in. DRC authorities have separately asked to roll out Ervebo for general use outside a clinical trial, a request backed by Africa CDC, though it remains unclear whether DRC can access sufficient doses from the 500,000-dose Gavi stockpile, which is controlled by the International Coordinating Group on Vaccine Provision (ICG). (STAT News/Helen Branswell, Aug 12, citing WHO Geneva briefing)
New (Aug 13) — Africa CDC: only ~10% of expected contacts listed; outbreak now spans 53 health zones: Africa CDC disclosed that just 10% of expected contacts have been listed — far short of the 95% operational target — and that only about 70% of those listed are being actively followed. Roughly four in five new infections are occurring outside known transmission chains, and more than 60% of deaths are happening in communities rather than treatment centres. The outbreak has now spread to 53 health zones across five provinces, up from 51, having expanded from just 11 health zones in one province at the May 15 declaration. Africa CDC nonetheless commended the DRC government for advancing a package of "bold and innovative measures," including large-scale vaccination planning and a village-centred response aimed at identifying every suspected case and death. (Africa CDC statement, CGTN, Aug 12)
Watch (Aug 13) — Israel's third suspected case still pending; no confirmed resolution found: The suspected case reported Aug 11 — a 24-year-old man hospitalized in isolation at Soroka Medical Center after returning from DRC with fever — had test results expected within 24 hours as of that report. No confirmed test-result announcement has been located as of this update. Both of Israel's two prior suspected cases this outbreak (at Sheba Medical Center and Rambam Health Care Campus) later tested negative; this is not yet a confirmed case.
Aug 12 — Death toll passes 2,000; case count rises to 4,381 / 2,011 deaths: DRC government data reported by AP/Al Jazeera puts the outbreak at 4,381 confirmed cases and 2,011 deaths as of Tuesday, August 11 — a CFR of 45.9% — up from the Aug 8 WHO/Africa CDC sitrep of 4,209/1,916. The death toll has now crossed 2,000 for the first time, and officials say more than 1,000 of those deaths occurred in just the last three weeks alone. It remains the fastest-growing Ebola outbreak on record and the second-largest ever documented, behind only the 2014–2016 West Africa epidemic (11,310 deaths). (AP via Al Jazeera, Washington Post, Euronews, Aug 11)
New (Aug 12) — WHO: outbreak actually began in February, months before declaration; suspected case under investigation in Israel: WHO Regional Director for Africa Dr. Mohamed Janabi told reporters August 10 that genomic sequencing indicates the outbreak's true start was February 2026 in Mongbwalu, Ituri — roughly three months before the May 15 official declaration — with early cases misattributed to malaria and typhoid, allowing undetected spread during that window. Separately, Israel's Ministry of Health said it is investigating a suspected case: a 24-year-old man who recently returned from DRC was hospitalized in isolation at Soroka Medical Center (Beersheba) with fever; results were expected within 24 hours as of Aug 11. This is the third such suspected case in Israel during this outbreak — the two prior cases both later tested negative — and it is not yet a confirmed case. Separately, Africa CDC said the DRC government is submitting a formal request to the ICG on August 12 to release Ervebo vaccine doses from the Gavi global stockpile, following national ethics and regulatory approval, to support the Phase 3 ring trial recommended Aug 7. (WHO/Africa CDC press briefings; Times of Israel, ynetnews, Aug 10–11)
New (Aug 11) — Case count rises to 4,209 / 1,916 deaths; Africa CDC shifts to door-to-door case-finding: The most recent WHO/Africa CDC sitrep (published Aug 8, data thru Aug 7) puts the outbreak at 4,209 confirmed cases and 1,916 deaths — a CFR of 45.5% — up 89 cases and 21 deaths from the prior day, with 595 patients hospitalized in isolation. Ituri remains most affected with 3,636 cases and 1,551 deaths across 28 of its 36 health zones. Separately, Bloomberg and the Japan Times reported August 10 that Africa CDC and partners are shifting from conventional contact tracing to active door-to-door case-finding in the hardest-hit areas, where widespread community transmission means almost anyone could have been exposed — the effort will deploy an estimated 25,000–30,000 community health workers. Officials explicitly caution the confirmed case count is likely to climb further in the coming weeks as previously undetected infections are found — a surveillance-capacity expansion, not necessarily a sign transmission itself is accelerating. (WHO/Africa CDC sitrep, Aug 8; Bloomberg/Japan Times, Aug 10)
New (Aug 11) — Child deaths pass 300: UN News reported August 7 that more than 300 children have now died in the outbreak. Children make up nearly a quarter of confirmed cases but almost a third of all deaths — a disproportionate mortality burden. WHO's Technical Advisory Group met for a third time on July 31 to review additional animal-study data on ERVEBO cross-protection ahead of the Phase 3 ring-trial recommendation issued Aug 7 (see below). Nearly one million people remain displaced by armed conflict in Ituri, with women and children accounting for roughly 80% of that displaced population — the same group bearing the heaviest share of Ebola mortality. (UN News, Aug 7)
New (Aug 9) — River-boat scare resolved: all Yingfeng 2 passengers test negative, vessel released: DRC's National Institute of Biomedical Research (INRB) confirmed on August 9 that every passenger and crew member screened aboard the quarantined Yingfeng 2 — not just the initial 7 reported August 7 — tested negative for Bundibugyo virus. The Health Ministry said the vessel was decontaminated and the quarantine at Maluku/Bende Bende port, 65km upstream from Kinshasa, has been lifted. This closes out the first concrete real-world test of the Kisangani–Congo River–Kinshasa corridor without a confirmed importation into the capital. Cholera screening was also conducted alongside the Ebola testing. (AP via Washington Post, ABC News, Aug 9)
New (Aug 7) — WHO recommends full-scale Phase 3 trial of the licensed ERVEBO vaccine against Bundibugyo: WHO's Technical Advisory Group on vaccine prioritization recommended that the licensed ERVEBO (rVSV-ZEBOV) vaccine — used successfully against the Zaire strain since 2018 — be fast-tracked directly into a Phase 3 ring trial in DRC to test possible cross-protection against Bundibugyo virus. This reverses WHO's earlier May 2026 recommendation against deploying ERVEBO in this outbreak. The recommendation rests on preclinical data showing 3 of 4 non-human primates vaccinated with ERVEBO survived Bundibugyo challenge, and a ferret study in which the research-grade version gave 100% protection. Gavi confirmed its 500,000-dose global Ebola vaccine stockpile will supply the ring trial, with some doses already in DRC. Because ERVEBO is an already-licensed, mass-manufactured product — unlike the small Phase 1 Oxford ChAdOx1 BDBV trial (50 participants) — this is the most significant near-term vaccine-access development since the outbreak began, though efficacy against this strain in humans remains unproven pending trial results. (Al Jazeera, Gavi, Aug 7)
Aug 6–7 — River boat carrying 255 passengers quarantined 65km from Kinshasa after 5 deaths; onboard tests negative so far: The Yingfeng 2, a Chinese-operated river boat that departed Kisangani (Tshopo Province) and travelled roughly 1,700km down the Congo River toward the capital, was intercepted and quarantined near Bende Bende/Maluku port — just 65km upstream from Kinshasa — on August 6. The alert was triggered after a passenger with fever and diarrhoea, who had disembarked in Mongala Province, died on July 25 with Ebola-like symptoms; DRC Health Minister Roger Kamba subsequently confirmed 5 total deaths connected to the vessel's journey — the index passenger plus two adults, a 3-year-old child and a newborn. WHO and Ministry of Health teams boarded the vessel with a mobile lab to screen all 255 passengers and crew; the first 7 tested came back negative on August 7, easing immediate concern, though Kamba cautioned the 21-day incubation window has not fully elapsed. Officials also clarified that Mongala Province itself has recorded no confirmed Ebola cases. This is the most concrete real-world test yet of the Kisangani–Congo River–Kinshasa transmission corridor this brief has long flagged as the highest-risk escalation pathway to the capital; Kinshasa authorities say surveillance and rapid-response capacity at the Maluku entry point are being reinforced. (BBC via Kahawatungu, Aug 6; US News/AP, Aug 7)
New (Aug 7) — Confirmed cases surpass 4,000 for the first time; DRC INRB now counts 4,053 cases / 1,850 deaths: The DRC's public health institute (INRB), reported by AFP via US News on August 7, puts the outbreak at 4,053 confirmed cases and 1,850 deaths — a CFR of 45.6% — up from the WHO/Africa CDC joint figure of 3,973/1,801 issued the day before. This is the first time confirmed cases have crossed the 4,000 threshold in this outbreak, which remains the fastest-growing Ebola epidemic on record, having reached this scale roughly ten weeks after the outbreak's May 15 declaration.
New (Aug 6–7) — Ebola virus reaches internally displaced persons camps in Ituri: UN News, citing UNHCR, reports the rapidly spreading Bundibugyo virus has now infected 19 internally displaced people, killing 5, across at least 5 of Ituri Province's 69 displacement camps. Camps housing some of the roughly 270,000 people displaced by armed conflict in Ituri typically lack adequate water and sanitation infrastructure, and residents often distrust health services — conditions UNHCR and WHO both flag as favorable to continued spread. This marks a new and higher-risk transmission environment beyond the health-facility and community settings already driving the outbreak.
Aug 6 — WHO/Africa CDC joint mission briefs President Tshisekedi; case count rises to 3,973/1,801, contact tracing at 75%, North Kivu beds at 139% of capacity: In a joint news release, WHO and Africa CDC reported the outbreak at 3,973 confirmed cases, 1,801 deaths and 776 recoveries across 51 health zones in five provinces as of August 4 — a CFR of 45.3% — with 99 new cases and 52 deaths in the latest 24-hour period. Contact follow-up stood at just 75%, well short of the 95% target needed to trace transmission chains quickly, and treatment-centre occupancy in North Kivu reached 139%, well past capacity, with 674 patients under care nationwide. Dr. Tedros, Africa CDC's Dr. Jean Kaseya, and WHO AFRO's Dr. Mohamed Janabi led a joint high-level mission August 4–6 through Kampala, Bunia and Kinshasa — visiting Bunia's Rwangole Ebola Treatment Centre and briefing President Félix Tshisekedi directly. The two agencies issued a ten-point call for an urgent, community-led scale-up of the response — faster case detection, contact follow-up at 95%+, care and testing brought closer to affected villages, timely pay and protection for frontline workers, and financing that reaches operations "without delay." Tedros: "In some areas of eastern DRC, the Ebola outbreak is outpacing our response." Kaseya: "Containing and ultimately stopping this outbreak will come from communities." (WHO/Africa CDC joint release, Aug 6)
New (Aug 4) — second Bundibugyo vaccine candidate enters trials in Canada; ERVEBO cross-protection data under review: WHO's Dr. Vasee Moorthy told reporters in Geneva that a second Bundibugyo-specific vaccine candidate has begun animal trials (ferrets and monkeys) in Canada, alongside the UK/Oxford ChAdOx1 BDBV candidate that entered human Phase 1 testing in July. Results from the DRC's post-exposure prophylaxis trial (obeldesivir) are also progressing, with more than 25 high-risk contacts enrolled and a fourth trial site opening in Ituri this week. Separately, WHO's technical advisory group met to review new animal-study data on whether the licensed ERVEBO vaccine (targeting the Zaire strain) offers any protection against Bundibugyo virus, with recommendations expected shortly. Moorthy cautioned that conclusive results on any candidate remain "several months" away. (UN News, Aug 4)
Superseded — Aug 4 DRC govt count jumps to 3,802 cases / 1,707 deaths; WHO warns of "exceptional" pace: The latest DRC government update, reported by AP on August 4, puts the outbreak at 3,802 confirmed cases and 1,707 deaths — a CFR of 44.9% — a sharp rise from WHO's July 30 count (3,605 / 1,587). On August 2 WHO said the epidemic is "intensifying" at an exceptional pace and called for a major scale-up of the response "to get ahead of the outbreak," citing insecurity, displacement and cross-border movement among roughly 270,000 people in Ituri displacement sites.
New (Aug 5) — Africa CDC: outbreak has grown "seven times faster" than 2014–16 West Africa; treatment capacity now ~1,000 beds: Speaking again in Bunia alongside WHO Regional Director for Africa Dr. Mohamed Janabi, Africa CDC's Kaseya said that after just 14 weeks the outbreak had grown seven times faster than the 2014–2016 West Africa epidemic did over the same period. The pair inaugurated a new Ebola treatment centre in Bunia; Janabi said treatment capacity has expanded to about 1,000 beds (up from 800) and daily lab testing remains above 2,000 samples (up from ~30 at the outbreak's start) — but stressed the response "remained insufficient as lives continued to be lost." No new case count, province, or PHEIC status change was reported. (Africanews, Aug 5)
Aug 4 — Africa CDC: "contact tracing is not working," peak timing unclear: Speaking in Bunia on his second visit to the epicentre, Africa CDC Director-General Dr. Jean Kaseya said it is not clear when the outbreak will peak and that 60–70% of new cases are now traced to community spread rather than known contact lists — "we don't like the trajectory of this outbreak, and it's already the second largest outbreak (ever) in the world." Patient zero has still not been identified, with displacement from armed conflict and illegal mining hampering efforts to trace thousands of contacts. WHO says it is now testing more than 2,000 samples a day (up from 20) and monitoring more than 17,000 contacts, with about 80% seen daily. WHO Director-General Tedros arrived in Kinshasa on August 4 and is expected to visit Bunia later this week. (AP/STAT)
New (Aug 3) — Mongbwalu health workers issue 24-hour pay ultimatum: Health care workers in the hard-hit town of Mongbwalu warned on August 3 that they would "escalate" action if unpaid wages were not resolved within 24 hours — the latest in a series of pay-related work stoppages (Bunia, July 13–15 and July 25) that have repeatedly disrupted patient care and contact tracing. WHO says more than 100 health care workers have been infected since the outbreak began. (AP)
Context (Aug 3) — outbreak formally confirmed as the largest ever recorded in DRC: Ahead of the Aug 4 AP figure above, WHO/UN OCHA confirmed the outbreak had surpassed DRC's 2018–2020 North Kivu epidemic (3,317 confirmed cases per UN News) to become the largest Ebola outbreak the country has ever recorded. Of the 49 affected health zones, 33 remain active with confirmed cases still being reported; Ituri Province accounts for 88% of all confirmed cases and 82.6% of deaths nationwide (UN OCHA/WHO, Aug 3). No new provinces, countries, or PHEIC status changes have been reported.
New (Aug 3) — DRC's largest Ebola treatment centre opens in Ituri: UN-backed health partners are inaugurating the country's largest Ebola treatment centre (100-bed capacity) this week, complementing a newly built Ebola transit centre at the Kigonze displacement camp on the outskirts of Bunia, set up with the US and International Medical Corps to speed identification and referral of suspected cases. WHO separately delivered 30 additional beds and 38 mattresses to Nizi (near Mongbwalu, Ituri), bringing that centre's capacity to 80 beds. WHO nonetheless says a substantial scale-up of response activity is still needed to get ahead of the outbreak, citing insecurity, displacement and cross-border movement among roughly 270,000 people sheltering in Ituri displacement sites — conditions WHO calls ideal for continued spread. Aid teams are also reporting the disease is causing stillbirths and premature deliveries among pregnant patients. (UN News / OCHA, Aug 3)
WHO (data through July 30) — 3,605 cases, 1,587 deaths, 49 of 140 health zones: WHO's latest situation report (DON-614) puts the outbreak at 3,605 confirmed cases and 1,587 deaths — a CFR of 44% — now spanning 49 of 140 health zones across the same five provinces (up from 47 on July 21). This WHO figure runs slightly ahead of the DRC Ministry's own July 31 press count (3,532 / 1,556 via Anadolu/Reuters), reflecting the ongoing reconciliation between national and WHO reporting streams described below. Including Uganda (20 cases, outbreak now closed) and France (1 case), the global cumulative stands at 3,626 cases and 1,589 deaths.
New — IHR Emergency Committee to reconvene August 18: WHO is preparing an updated Rapid Risk Assessment ahead of the next meeting of the IHR Emergency Committee on this outbreak, scheduled for August 18, 2026. The Committee will reassess whether the epidemic continues to meet the criteria for a Public Health Emergency of International Concern and may revise its temporary recommendations — the first substantive PHEIC review since the May 22 first-meeting recommendations.
Latest (DRC Ministry, July 31) — 3,532 cases, 1,556 deaths: The latest DRC Ministry figures put the outbreak at 3,532 confirmed cases and 1,556 deaths — a CFR of 44.1%, with 807 patients in isolation or hospital and 626 recovered. The death toll rose roughly 50% over the past week; Africa CDC says the sharp jump partly reflects a backlog of cases and deaths not previously confirmed or recorded. It remains the fastest-spreading Ebola epidemic ever documented. Confirmed spread still covers five provinces — Ituri (epicentre, ~90% of all cases), North Kivu, South Kivu, Haut-Uele and Tshopo (which includes the major city of Kisangani). WHO continues to warn the confirmed caseload understates true transmission by a factor of up to 4 given surveillance gaps in conflict-affected zones.
New (July 31) — Now the world's second-largest Ebola outbreak on record: With 3,532 confirmed cases, the outbreak has surpassed the DRC's own 2018–2020 North Kivu epidemic (~3,470 cases, Aug 2018–Jun 2020) to become the second-largest Ebola outbreak ever documented. Only the 2014–2016 West Africa epidemic (28,616 cases, 11,310 deaths across Guinea, Liberia and Sierra Leone) was larger. Less than three months in, the disease has killed five times as many people as previous outbreaks had by the same stage (Africa CDC). Carl Skau, acting head of the UN World Food Programme, called it "the fastest spreading Ebola epidemic that we have ever seen" and warned "the world needs to pay much more attention." Africa CDC now estimates it would take $1.4 billion to contain the outbreak — three times its earlier estimate.
Deaths are now mostly happening in the community (Africa CDC, July 30): Africa CDC Director-General Dr. Jean Kaseya reported that 63% of confirmed deaths in the last two weeks occurred outside treatment centres — largely due to the "unsafe handling of infected bodies" by residents, including touching highly infectious remains. This is a decisive containment failure: it means transmission is being driven by traditional burial practice and delayed care-seeking in communities that distrust the response, not by gaps inside clinical facilities. It compounds the July 15 hospital/ETC attack in Ituri's Nyakunde zone, which forced international partners to temporarily relocate and disrupted surveillance, contact tracing and supplies.
New (July 28) — Uganda declares its outbreak over: Uganda's Ministry of Health officially declared an end to its 2026 Ebola outbreak on July 28, closing a 20-case outbreak (18 recoveries, 2 deaths) with no sustained community spread. Notably, the declaration came ahead of WHO's standard 42-day countdown — Uganda's last patient was discharged July 16, placing it only ~12 days into the two-incubation-period window — with Health Minister Chris Baryomunsi citing evidence that transmission had been interrupted. Uganda is keeping its border with DRC closed and maintaining intensified border-district surveillance. Because transmission continues across the border in DRC, any new imported case would reopen the outbreak. (Incorporates team field note, Jul 29: Uganda declared Ebola-free early, before the full 42-day period; border surveillance continues.)
Health workers strike again (July 25): Staff at an Ebola treatment centre in the eastern DRC epicentre walked out again on Saturday, July 25, demanding unpaid wages — the second such stoppage this month. The walkout disrupted patient care at the heart of the outbreak and directly threatens the already-collapsing contact-tracing effort (reported by AP via Daily Sabah and DNYUZ).
Death toll milestone — 1,000 crossed in under 10 weeks (Africa CDC, July 23): At a health summit in Ghana on July 23, Africa CDC Director-General Dr. Jean Kaseya confirmed the toll had reached 1,031 — the outbreak crossed 1,000 deaths faster than any Ebola outbreak on record; the 2013–2016 West Africa epidemic took roughly eight months to reach the same toll. Kaseya's warning: "If we do not stop this outbreak today, it could become one of the worst Ebola outbreaks the world has ever documented… people are dying because we don't have vaccines, we don't have medicine, we don't have funding." (The toll passed 1,400 within days and reached 1,556 by the July 31 data — see above.)
Response capacity vs. transmission (context): Earlier this week WHO pointed to improved response capacity — contact follow-up nearing 80%, expanded laboratory and treatment capacity, and a slowing rate of increase in some health zones. But the latest national data (July 26) show the epidemic still growing, and any tentative "stabilization" signal is fragile and reversible, driven by surge support rather than an underlying break in transmission — it does not indicate the outbreak has peaked. Two localised bright spots hold: Kisangani has recorded no secondary cases — all five Tshopo cases remain importations from Ituri with no onward local spread detected — and in Kinshasa, contacts of the France-linked case remain under active follow-up with no confirmed capital transmission.
New (July 13) — Oxford begins Phase 1 vaccine trial (BD-Ebov): The University of Oxford has launched the world's first Phase 1 human trial of a candidate Bundibugyo vaccine — the ChAdOx1 BDBV vaccine, tested for safety and immunogenicity in 50 healthy adults aged 18–55 in Oxford. Follow-on studies are being prepared with the MRC/Uganda Virus Research Institute and LSHTM Uganda, pending regulatory approval. While a licensed, deployable BDBV vaccine remains far off, this is the first vaccine specifically targeting this strain to enter clinical testing — the most concrete step yet toward closing the countermeasure gap that defines this response.
Security incident (July 15) — Ebola treatment centre attacked in Bunia: WHO Director-General Tedros confirmed at the July 16 Geneva media briefing that an Ebola treatment centre in Bunia was attacked on Wednesday, July 15. Active armed conflict continues to hamper operations across Ituri and complicates efforts to reach affected communities. This compounds the health-worker strike over unpaid wages reported July 13–15 at the same facilities.
Community mistrust is undermining the response (ongoing): Local populations in Ituri continue to view the outbreak response with deep skepticism, and this mistrust is now a primary driver of continued transmission. Fear, rumours and hostility toward outside responders have produced attacks on Ebola treatment centres, resistance to burial teams, and suspected patients escaping isolation facilities; residents in Rwampara burned an ETC after tensions over the handling of a suspected Ebola death. Social-science teams (SSHAP, Mercy Corps, MSF) document a recurring "Ebola is a business" narrative and suspicion of responders' motives — the same dynamic that prolonged the 2018–2020 North Kivu outbreak. With no vaccine to offer and 80% of cases already off contact lists, rebuilding community trust — door-to-door engagement by local health workers and religious leaders — is as decisive to containment as any clinical countermeasure. (Team field note, Jul 28: "Locals continue to view outside assistance skeptically.")
Funding gap (July 16) — $400M+ shortfall: The joint WHO / Africa CDC continental preparedness and response plan still faces a funding gap of more than $400 million. UNICEF separately warned that only 25% of the funding required for its Ebola response is currently available. Tedros: "We urge donors to fill this gap… This is not charity. It's an investment in national security." Response capacity has nonetheless grown — treatment capacity now exceeds 800 beds, laboratory capacity has risen from 1 to 16 labs, contact follow-up rates have reached nearly 80%, and more than 21,000 community health workers are being trained.
Response crisis (July 13–15): Front-line health workers across Ituri — including epidemiological surveillance teams, case investigators, community outreach workers, burial teams, drivers and gravediggers — have begun striking over unpaid wages and bonuses dating to the outbreak's May 15 declaration. Staff obstructed the entrance to Bunia General Hospital and walked out at Rwampara General Hospital. Workers agreed to resume under a 72-hour government payment deadline; Health Minister Roger Kamba says authorities are verifying the payroll after unrelated names were added. A surveillance and burial-team stoppage at the epicenter directly threatens the already-collapsing contact-tracing effort.
Bright spot — Uganda outbreak declared over (July 28): Uganda discharged its last Ebola patient from the Mulago National Referral Isolation Centre on July 16 and, on July 28, its Ministry of Health officially declared the outbreak over — doing so ahead of WHO's full 42-day (two-incubation-period) countdown, which would otherwise have run to ~August 27. Uganda's outbreak totaled 20 confirmed cases, 18 recoveries and 2 deaths, of which 15 were imported from DRC and 5 locally acquired; no new case had been reported since June 21. Uganda is keeping its DRC border closed and maintaining intensified surveillance; WHO cautions that because transmission continues in DRC, a new imported case would reopen the outbreak.
No vaccine exists for this strain. ERVEBO (rVSV-ZEBOV) — used successfully in the 2018–2020 DRC outbreak — does not protect against Bundibugyo virus. WHO formally recommended against deploying it. There is zero approved countermeasure for BDBV.
1. Bundibugyo is a rare, poorly understood strain. Only the third known human outbreak of this ebolavirus species in history. The prior two were in Uganda (2007–2008, 149 cases) and DRC (2012, 57 cases). Genomic sequencing published May 2026 confirmed this is a new spillover from an unknown animal reservoir — not descended from either prior outbreak.
2. Contact tracing has effectively failed. WHO's own emergencies director confirmed that 80% of newly confirmed patients have no link to any known contact list. In a vaccine-era outbreak, imperfect tracing can be compensated by ring vaccination. Here, no such ring exists.
3. The capital is on alert. DRC has banned public gatherings in Kinshasa (17 million people) and three other provinces as a precaution. An earlier suspected Kinshasa case tested negative on confirmatory testing (WHO, May 17), and no sustained transmission has been confirmed in the capital as of WHO's July 9 report. But just 1km across the Congo River sits Brazzaville — Republic of Congo's capital, equally connected to global air networks. Sustained transmission in either city would fundamentally change the outbreak's geography.
4. The outbreak has already left Africa. A response worker who had been in DRC traveled to France in late June and tested positive — the first confirmed case outside Africa in this outbreak. International importation chains have begun.
5. Estimated true scale is up to 4× larger. WHO estimates the confirmed figure of ~3,532 understates the real outbreak size by a factor of up to four, due to the surveillance collapse in conflict-affected zones of Ituri Province.
Outbreak Profile
| Pathogen | Bundibugyo ebolavirus (BDBV) · Orthoebolavirus bundibugyoense |
| Index case | April 24, 2026 · Mongbwalu Health Zone, Ituri Province, DRC |
| Official declaration | May 15, 2026 · DRC Ministry of Health (17th Ebola outbreak in DRC) |
| PHEIC declared | Active WHO Director-General, May 17, 2026 |
| Vaccine status | None approved No licensed BDBV-specific vaccine yet · Phase 3 recommended WHO/Gavi fast-tracking ERVEBO into a DRC ring trial (Aug 7) · Phase 1 Oxford ChAdOx1 BDBV candidate in first-in-human trial (Jul 2026) |
| Treatment trial | Enrolling PARTNERS trial — MBP134 + remdesivir — started July 2, 2026 |
| Prophylaxis trial | New EBO-PEP — post-exposure prophylaxis with obeldesivir — launched July 14, 2026 (INRB, DRC & Uganda) |
| Provinces affected | 6 (DRC list) Ituri (epicenter, ~86% of cases), North Kivu, South Kivu, Tshopo (incl. Kisangani), Haut-Uele & Bas-Uele (Buta health zone added to DRC's national affected-areas list, per CGTN/Xinhua Aug 15; not yet formally added to WHO's own affected-province list per prior reporting) — now 55 health zones. Total 4,945 cases · 2,325 deaths, CFR ~47.0%, 1,040 recoveries, 730 hospitalized in isolation (DRC INSP/government data, reported Aug 17, data thru Aug 16) · now the deadliest Ebola outbreak in DRC's history, surpassing the 2,299 deaths of the 2018-2020 North Kivu epidemic · WHO's Tedros warns it could eventually eclipse the 2014-16 West Africa epidemic's death toll if not scaled up. Contact follow-up at 82.6% of registered contacts (DRC government report, Aug 16; was 82.4% in WHO AFRO Weekly External Sitrep 13, data thru Aug 9); separately, only ~10% of expected contacts have been listed in the first place (target 95%) — Africa CDC's Kaseya, Aug 13: "the concept of contact tracing in DRC has become useless." ~4 in 5 new infections outside known transmission chains; more than 63% of deaths now occurring in communities rather than treatment centres or hospitals (Africa CDC's Kaseya, Aug 16 — up from 60%+ on Aug 12). Africa CDC is pushing a village-based response that would retrospectively reconstruct the undocumented Feb–May pre-declaration period via community recall; WHO's Chikwe Ihekweazu says the virus may have circulated 2–3 months before formal detection (Aug 16). Virus has reached at least 5 of Ituri's 69 IDP camps (19 infected, 5 dead — UNHCR, Aug 6–7). Child deaths have passed 300 (UN News, Aug 7). Genomic study (Nature Medicine, Aug 13) finds the outbreak began with a new, independent animal-to-human spillover distinct from the 2007/2012 Bundibugyo lineages. Africa CDC's Kaseya has requested 100,000 Ervebo doses from the ICG for expanded emergency vaccine use beyond the Phase 3 ring trial (Aug 13-15). WHO Director-General Tedros warns the outbreak is on track to become the largest Ebola epidemic ever recorded if current pace continues (Aug 12); Africa CDC's Kaseya warns it could run "more than a year" and become the largest in the world if unstopped (Aug 13-14); WHO's moderate projection has it peaking within 6 months (severe scenario: 9-12 months). Mercy Corps flags cases ~35km from the South Sudan border — no confirmed South Sudan cases yet. Ten further provinces incl. Kinshasa designated high-risk for preparedness. |
| International spread | Uganda: 20 cases, 2 deaths Declared over Jul 28 (border with DRC kept closed) · France: 1 case (first outside Africa, Jun 24) · Germany: 2 evacuated US cases (1st recovered; 2nd medevac'd Jul 13) |
| U.S. advisory | Level 3 Reconsider Travel to DRC · Entry-suspension order renewed July 13, 2026 — in force 30 days (through ~Aug 12, 2026) |
| Closest historical comp. | 2014–2016 West Africa (28,612 cases) — this is #3 at current trajectory |
U.S. Cases
Two Americans Infected — Second Case Evacuated to Germany
First case (confirmed, named): Dr. Peter Stafford, a missionary surgeon with Serge (Pennsylvania-based Christian missions organization). Exposed during surgery at Nyankunde Hospital, Bunia. Evacuated to Charité University Hospital, Berlin. Recovered and returned to the U.S. in early June 2026.
Second case (confirmed July 10, medevac July 13): Described by CDC as "a U.S. citizen working for a humanitarian organization in DRC." Per ECDC and CDC updates, the patient tested positive for Bundibugyo virus on July 10 and was medically evacuated to Germany on July 13, 2026. Identity, employing organization and current clinical condition remain undisclosed. CDC is working with the patient's employer, other federal agencies, and DRC partners to identify high-risk contacts and prevent onward transmission.
Update (July 15): The second US case is now confirmed and evacuated — the third medical evacuation to Europe in this outbreak (after Berlin for the first US case and France's own imported case). This marks a second active importation chain into Germany. No secondary transmission from any evacuated case has been reported. Clinical outcome pending.
Vaccine & Treatment Gap
ERVEBO Does Not Protect Against Bundibugyo
This is the critical structural difference from every prior DRC outbreak since 2018. The CDC's Health Alert Network (HAN-00530) states explicitly:
"There is currently no FDA-licensed or authorized vaccine to protect against Bundibugyo virus infection. The Ebola vaccine licensed in the United States (ERVEBO®) is indicated for preventing Ebola disease due to a different species... and based on studies in animals, this vaccine is not expected to protect against Bundibugyo virus."
WHO advisors formally recommended against deploying ERVEBO in this outbreak in May 2026. The Mvabea/Zabdeno regimen (Janssen) also targets only the Zaire strain.
New (Aug 7) — ERVEBO fast-tracked into Phase 3 ring trial against Bundibugyo: WHO's Technical Advisory Group recommended the licensed ERVEBO (rVSV-ZEBOV) vaccine be prioritized for a Phase 3 ring trial in DRC against Bundibugyo virus, reversing its May 2026 recommendation against deployment. Preclinical data showed 3 of 4 vaccinated non-human primates survived Bundibugyo challenge and a ferret study found 100% protection with the research-grade formulation. Gavi's 500,000-dose global stockpile will supply the trial, with doses already in-country — a far larger-scale vaccine option than the 50-participant Oxford Phase 1 study below, though human efficacy against this strain remains unproven. (Al Jazeera, Gavi, Aug 7)
First BDBV vaccine enters human testing (July 13, 2026): The University of Oxford has launched its Phase 1 BD-Ebov trial of the ChAdOx1 BDBV vaccine in 50 healthy adults (18–55) — the first vaccine specifically targeting this strain to reach clinical testing, with follow-on studies planned in Uganda (MRC/UVRI, LSHTM). Phase 1 assesses only safety and immunogenicity in a small cohort, so any licensed, deployable product remains many months to years away and will not affect the current outbreak's trajectory. It is nonetheless the most concrete long-term step yet toward closing the countermeasure gap.
Treatment Trial — Only Active Countermeasure
The PARTNERS trial (Platform Adaptive Randomised Trial for New and Repurposed Filovirus TreatmentS), co-sponsored by WHO, INRB, ALIMA, and MSF, began enrolling patients on July 2, 2026 in Ituri Province. It tests MBP134 (Mapp Biopharmaceutical monoclonal antibody cocktail, originally developed specifically for BDBV) and remdesivir (Gilead antiviral, widely used for COVID-19), versus optimized supportive care. This is the most important variable to watch: early efficacy signals in August could materially change the outbreak trajectory.
New — post-exposure prophylaxis: On July 14, 2026, INRB launched EBO-PEP, the first trial to assess post-exposure prophylaxis with the antiviral obeldesivir in high-risk contacts across DRC and Uganda. If effective, a prophylactic taken after exposure could partially substitute for the ring-vaccination strategy that is unavailable against BDBV — a potentially significant tool given that 80% of new cases fall outside known contact lists.
Predicted Trajectories
Trajectory A
20%
Controlled Containment
Treatment trial turns the tide · Outbreak over by Dec 2026
- MBP134 shows rapid efficacy — CFR drops below 10% within 45 days of deployment
- Emergency vaccine candidate fast-tracked under compassionate use by Aug 2026
- International surge (MSF, WHO, USAID) restores contact tracing in Bunia
- Kinshasa transmission stays limited — ring containment holds
- Peak ~2,500 cases · Declared over Nov–Dec 2026
Requires: treatment trial results within ~30 days AND humanitarian access in armed zones
Trajectory B — Most Likely
50%
Prolonged Regional Epidemic
6–12 months · 5,000–15,000 total cases
- Contact tracing never recovers — 80% case gap is structural, not temporary
- Kinshasa becomes a sustained transmission zone by Aug–Sep 2026
- Cases spread to South Sudan, Burundi, Rwanda via land corridors
- Treatment trial reduces CFR but cannot replace vaccines at population scale
- Multiple international importations following France — Gulf states, EU hubs
Driver: Armed conflict + urban spread + no vaccine = containment requires paradigm shift in international response
Trajectory C
25%
Continental Escalation
Exceeds 2014–2016 West Africa scale
- Kinshasa–Brazzaville corridor (capitals, 1km apart) becomes bi-national epicenter
- Lagos, Nairobi, Johannesburg report community transmission via air hubs
- Treatment trial results delayed or inconclusive
- Conflict escalation forces evacuation of response teams in eastern DRC
- WHO elevates to "pandemic emergency" under revised IHR framework
- 20,000–50,000 total cases — comparable to 2014–2016
Trigger: Kinshasa sustained transmission + one hub city importation. Once Lagos or Nairobi sees community spread, probability cascades rapidly.
Trajectory D
5%
Global Health Catastrophe
Multi-continent sustained transmission
- Concurrent crises prevent any coherent DRC response
- Sustained community transmission chains established in Western countries
- All vaccine candidates fail; MBP134 shows limited efficacy
- Requires COVID-19-level global mobilization to contain
Note: Ebola's fluid-contact transmission mechanism makes this significantly less probable than with respiratory pathogens. Requires simultaneous failure across multiple containment systems.
The Kinshasa Variable
Why Kinshasa Is the Variable to Watch
Status (as of Jul 19): No sustained transmission has been confirmed in Kinshasa. A single earlier suspected case in the capital tested negative on confirmatory testing (WHO, May 17). As a precaution, DRC authorities have banned public gatherings in Kinshasa and three other provinces. The concern is structural rather than realized: Kinshasa sits directly across the Congo River from Brazzaville — the Republic of Congo's capital — separated by approximately 1 kilometer of water. Both cities are major regional air hubs, collectively connected to Lagos, Nairobi, Johannesburg, Paris, Brussels, and Doha.
In prior DRC outbreaks, geographic containment was achievable because outbreaks remained in remote rural areas. The 2018–2020 North Kivu outbreak (same geography, Zaire strain) reached the provincial city of Butembo but never Kinshasa. The current outbreak has now crossed that threshold.
Watch item — Kisangani is the river bridgehead. Tshopo province now reports 5 cases (4 deaths) across 3 of 23 health zones, seeded when a pregnant woman who died in Bunia on June 27 was transported to Kisangani, where her body tested positive on June 30. Investigators assess both the Tshopo and Haut-Uele clusters as importations from Niania in Ituri — human movement, not independent spillover. Kisangani sits ~500 km west of the epicentre on the Congo River, the main transport corridor linking eastern DRC to Kinshasa. This is the mechanism by which the outbreak would reach the capital, and it is now active.
New (Aug 6) — the corridor produced its first real test case. A 255-passenger boat that left Kisangani travelled the full ~1,700km river route toward Kinshasa before being intercepted and quarantined just 65km from the capital, after a passenger who disembarked upriver in Mongala Province died July 25 with Ebola-like symptoms. DRC officials confirmed 5 deaths tied to the journey; the first 7 onboard passengers tested negative on Aug 7, but the 21-day incubation window is still open. Kinshasa authorities are reinforcing surveillance capacity at the Maluku river entry point as a result.
The Kinshasa–Brazzaville scenario is the single most dangerous escalation pathway. Both cities combined have a population exceeding 20 million people and some of the highest urban population densities in sub-Saharan Africa. Sustained community transmission in either city would be extraordinarily difficult to contain without a vaccine ring strategy.
Platform Context
This Is the Exact Scenario VitaAlert Is Built For
The three critical intelligence gaps this outbreak exposes — offline field reporting in conflict zones, AI risk scoring when 80% of cases are off contact lists, and cross-border corridor monitoring — are precisely the problems the VitaAlert platform is designed to solve.
This is not a theoretical use case. The outbreak is live, the surveillance failure is documented by WHO, and the gaps are causing preventable deaths. The case for epidemic intelligence infrastructure in emerging markets has rarely been more visibly demonstrated.
Intelligence briefs like this one will be published daily by the VitaAlert team during the active PHEIC. Team members can submit comments and corrections via the feedback panel. Reports are AI-verified against primary CDC, WHO, ECDC, and peer-reviewed sources before publication.